Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System
2022 · Advances in Therapy · 39 citations
https://doi.org/10.1007/s12325-022-02346-4